Table 1

Demographics, clinical information and health behavior
MS Patients (n = 37) Controls (n = 25) statistic p-value
Demographics
Age M(SD) 39.7 (12.8) 38.4 (11.9) 0.40a 0.69
Female sex, n (%) 28 (75.6) 18 (72.0) 0.11b 0.75
Health Behavior
Tobacco users, n (%) 14 (37.8) 6 (24.0) 1.31b 0.25
Body Mass Index, M(SD) 22.7 (5.7) 23.8 (3.8) - 0.89a 0.41
Physical activity/week, n (%)
< 1x 10 (27.0) 7 (28.0)
1-2x 20 (54.1) 12 (48.0) 0.30b 0.86
> 3x 7 (18.9) 6 (24.0)
Clinical Information
MS course, n (%)
Relapsing-remitting 26 (70.3)
Secondary progressive 8 (21.6)
Clinically isolated syndrome 3 (8.1)
MS Duration in years, M(SD)
Relapsing-remitting 6.4 (7.8)
Secondary progressive 6.4 (5.6)
EDSS median (range)
Mild MS 2 0 – 3.5
Moderate MS 4 4 – 5
MS treatment, n (%)
Yes 25 (80.6)
No 12 (19.4)

a t-test.

b chi square test.

Burschka et al.

Burschka et al. BMC Neurology 2012 12:161   doi:10.1186/1471-2377-12-161

Open Data